FDA Okays First Sublingual Med for Agitation in Schizophrenia, BD ...Middle East

The FDA has approved dexmedetomidine (IGALMI, BioXcel Therapeutics) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults. FDA Approvals

Hence then, the article about fda okays first sublingual med for agitation in schizophrenia bd was published today ( Friday 08/04/2022 - 10:22 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Okays First Sublingual Med for Agitation in Schizophrenia, BD )

Also on site :

• The Official Happiest Country in the World Has Charming Seaside Towns, Castles, and Unique Experiences
• El Líbano insta a Trump a intervenir para que Israel deje de bombardear el país: van más de 1.000 muertos
• ‘The Pitt’ Star Lucas Iverson Breaks Down Ogilvie’s Brutal Wake-Up Call: 'He’s Being Obliterated' (Exclusive)